The effects of fragrances on human arousal are not well understood. The aim of the present investigation was to determine the influence of two monoterpenes, 1,8-cineol and (±)-linalool, on human sustained attention, physiological arousal and wellbeing. The substances, as well as appropriate placebos, were administered either by inhalation or by skin application to a total of 130 healthy subjects. We found that when the fragrances were applied to the skin 1,8-cineol improved speed of attentional performance in comparison to (±)-linalool, but not in comparison to peanut oil, which served as a placebo. Under the same conditions, 1,8-cineol increased respiration rate in comparison to both (±)-linalool and placebo. In the inhalation condition, neither attentional performance nor physiological arousal were affected by the fragrances, but both odorants influenced wellbeing, i.e., 1,8-cineol decreased activation and (±)-linalool increased it. In contrast, no such effects were observed in the skin application condition. Our results demonstrate that fragrances affect cognitive performance, physiological arousal and wellbeing as a function of the mode of administration.
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To date, a number of investigations have demonstrated that essential oils and fragrances affect attentional functions in healthy human subjects [1] [2] [3] [4] . However, it is not well understood how such effects are exerted. It has been proposed that the effects of odorants may be elicited by several mechanisms. These mechanisms can roughly be divided into psychological and pharmacological mechanisms and differ in terms of structure-response relationships, i.e., substance specificity, doseresponse relationships and involvement of cognitive mediation [5] . The aim of the present study was to investigate the effects of two fragrances on cognitive performance, physiological arousal and ratings of well-being. 1,8-Cineol (C) and (±)-linalool (L) were chosen as odorants in this study based on the findings of previous investigations indicating stimulant and relaxing/sedating effects, respectively, in experimental animals [6] [7] [8] and humans [9, 10] . We hypothesized that C would lead to increased arousal and improved cognitive performance due to its activating effect, whereas L would lower arousal and impair vigilance performance due to its relaxing effect. In addition, the impact of different routes of administration was explored to test the hypothesis that different mechanisms are involved in the effects of fragrances on humans.
The factor analysis on the differences derived from the vigilance task yielded two meaningful principal components (i.e., eigenvalues ≥ 1) representing accuracy and speed, respectively ( Table 1 ). The univariate ANOVAs revealed no significant effect of group on the accuracy factor, but a significant effect NPC Natural Product Communications of group on the speed factor (F 5,123 = 2.670, P = 0.025). The post hoc comparisons showed that speed differed significantly between the 1,8-cineol skin application group (CS) and the (±)-linalool skin application group (LS) (P = 0.003) and tended to differ between CS and the placebo skin application group (PS) (P = 0.084) and between the placebo inhalation group (PI) and PS (P = 0.093). The ANOVA on the difference of reaction time (RT) showed no significant effect of group, however a two-sample t-test revealed a trend towards significance between CS and LS (P = 0.075), which indicated that subjects in the CS group tended to react faster in the second trial compared to the first trial than those in the LS group ( Figure 1 ).
The ANOVA on the differences of delayed reactions (DR) did not show a significant effect of group, but a marginally significant effect of group was found when only the groups in the skin application condition (S) condition, i.e., CS, LS and PS, were analyzed (F 2,60 = 2.749, P = 0.072). Post hoc pair-wise comparisons indicated a significant difference between CS and LS (P = 0.023). Subjects in the CS group made significantly more delayed reactions than those in the LS group ( Figure 2 ).
No significant effect of group was found on the number of false alarms (FA), misses (M) and hits (H).
Three meaningful principal components emerged from the factor analysis of the differences of physiological arousal (Table 1) , which were interpreted as electrodermal activity (EDA), tension and cardio-respiratory activity (CRA), respectively. Separate ANOVAs on these principal components did not show any significant group effects. In contrast, a significant effect of group was revealed for the difference of inter-beat interval (IBI) (F 5,122 = 2.378, P = 0.042). Post hoc comparisons showed
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Natural Product Communications Vol. 3 (7) 2008 1105 trends towards significance between the 1,8-cineol inhalation group (CI) and CS (P = 0.078), between the (±)-linalool inhalation group (LI) and LS (P = 0.080) and between the placebo inhalation group (PI) and PS (P = 0.096), indicating that the inter-beat interval in the second trial when compared with the first trial tended to increase (i.e., heart rate decreased) more in the S condition than in the inhalation (I) condition independent of the substance applied ( Figure 3 ). A significant group effect was also found for the difference of respiration rate (RR) (F 5,121 = 3.092, P = 0.012) and pair-wise comparisons revealed that CS differed significantly from CI (P = 0.016), from LS (P = 0.002) and from PS (P = 0.001), i.e., respiration rate in the second trial compared to the first trial increased significantly more in the CS group than in the other groups ( Figure 4 ).
Non-specific fluctuations of skin conductance (NS-SCR), skin conductance level (SCL), surface electromyogram (EMG) and blink rate (BR) did not vary as a function of group.
The factor analysis on the differences of well-being yielded two meaningful principal components for each set of differences. With regard to the lead components, the factors were interpreted as representing activity and relaxation, respectively ( Table 2 ). The univariate ANOVAs showed a significant effect of group on the activity factor of the differences 1-3 (F 5,123 = 3.648, P = 0.004), but not of the differences 2-4. The post hoc pair-wise comparisons indicated that activity 1-3 differed significantly between LI and PI (P = 0.007) and between LI and LS (P = 0.001). A strong trend toward significance was also observed between CI and CS (P = 0.059). No significant group effect was found for any of the relaxation factors. The ANOVA on the difference 1-3 of vigor (V) revealed a significant effect of group (F 5,124 = 3.718, P = 0.004).
The post hoc pair-wise comparisons showed significant differences between CI and CS (P = 0.024), between LI and PI (P = 0.002) as well as LS (P = 0.002), and a strong trend toward significance between CI and CS (P = 0.053). Subjects in the CI group felt more vigorous on rating 3 compared to rating 1 than those in the PI and CS groups, and subjects in the LI group felt more vigorous than those in the PI and LS groups ( Figure 5 ). Similarly, the ANOVA on the difference 2-4 of V showed a significant effect of group (F 5,122 = 3.315, P = 0.008).
The post hoc pair-wise comparisons indicated that subjects in the LI group felt significantly more vigorous on rating 4 compared with rating 2 than those in the CI group (P = 0.011), the PI group (P = 0.012) and the LS group (P = 0.000) ( Figure 5 ).
The ANOVA on the difference 1-3 of mood (M) showed a significant effect of group (F 5,124 = 4.144, P = 0.002). The post hoc pair-wise comparisons demonstrated that subjects in the LI group felt more cheerful on rating 3 compared to rating 1 than those in the PI group (P = 0.036) and the LS group (P = 0.000). They also tended to feel more cheerful than subjects in the CI group (P = 0.089) ( Figure 6 ). The ANOVA on the difference 2-4 of M just failed to reach significance (F 5,121 = 2.204, P = 0.058). The post hoc pair-wise comparisons showed that on rating 4 compared to rating 2 subjects in the LI group felt significantly more cheerful than those in the PI group (P = 0.002) and tended to feel more cheerful than subjects in the CI group (P = 0.060) ( Figure 6 ).
No significant effects of group were observed for alertness (AL), attentiveness (AT), calmness (C) and stress (S).
The univariate ANOVAs on the differences of the odor ratings showed significant group effects for the differences 1-3 of pleasantness (P) (F 2,64 = 6.090, P = 0.004), intensity (I) (F 2,64 = 18.828, P = 0.000) and effect (E) (F 2,63 = 22.752, P = 0.000), as well as for the differences 2-4 of I (F 2,63 = 14.421, P = 0.000) and E (F 2,64 = 6.952, P = 0.002). No group effect on the difference 2-4 of P was observed. The post hoc pairwise comparisons indicated that on rating 3 compared to rating 1 the odors of C and L were rated more pleasant (P = 0.009 and P = 0.004, respectively), more intense (P = 0.000 for both) and more stimulating than placebo (P) (P = 0.000 for both). On rating 4 compared with rating 2, C and L were rated stronger (P = 0.000 and P = 0.001, respectively) and more stimulating than P (P = 0.002 for both). In addition, C tended to be rated more intense than L (P = 0.055) ( Figure 7 ).
In our investigation, we found that vigilance performance, parameters of physiological arousal and ratings of well-being were affected differently not only as a function of the odorant applied to healthy human subjects, but also dependent on the form of administration of the substances. Specifically, we found the expected stimulating and relaxing effects of 1,8-cineol and (±)-linalool, respectively, only when these fragrances were applied to the skin of healthy subjects who were not able to evaluate odor qualities, such as pleasantness, intensity and effect. On the other hand, when the same fragrances were inhaled they affected ratings of well-being in a way contradicting our hypotheses, whereas an influence on cognitive or physiological arousal was not observed. These findings are in line with earlier results presented by our group [1, 11, 12] and highlight the possibility that different mechanisms of action are involved in the effects of fragrances on human arousal and cognition [5] . Thus, we conclude that the effects of odorants after inhalation are mainly psychological and overlay pharmacological mechanisms which are accessible when fragrances are applied by administration routes that exclude the olfactory system.
Experimental

Subjects and experimental design:
A 3 (substance) x 2 (condition) x 2 (trials) factorial design with repeated measures was employed. The conditions were inhalation and topical application to the skin. Each of the two trials consisted of a 20 min. administration period and a 30 min. vigilance task. 130 healthy human subjects (52 males and 78 females, mean age 27.9 ± 6.3 years) were assigned at random to one of 6 groups, i.e., CI, CS, LI, LS, PI and PS. Subject numbers, sex of subjects, mean age and handedness as assessed by the Edinburgh Handedness Inventory [13] are summarized in Table  3 . All subjects were tested in individual sessions following an A-B regimen. In the first trial, all subjects received a placebo. In the second trial, subjects in the odorant groups received either C or L while subjects in the control groups received the placebo again. All subjects gave their informed consent prior to inclusion in the study and were free to withdraw at any time.
Fragrance and placebo administration: C ("Eucalyptol", 99%, CAS 470-82-6, Aldrich, 89555 Steinheim, Germany) and L (CAS 78-70-6, containing 52% R-(-)-linalool and 48% S-(+)-linalool; Dragoco GmbH, 1230 Vienna, Austria) were administered either by inhalation (I condition) from an olfactometer (Olfactometer OM4, Heinrich Burghart Elektro-und Feinmechanik GmbH, 22880 Wedel, Germany) or by topical application to the skin (S condition).
In both conditions, the total administration time was 20 min. In the I condition, C and L were presented monorhinally at a concentration of 1.08 ppm and 99.8 ppb, respectively. The odor stimuli were embedded in a continuous, humidified air stream heated to 37°C and were presented for 30 sec with an inter-stimulus interval of 30 sec during which odorless air was delivered to the subject's nostril. At all times the total flow rate from the olfactometer was 8.0 L/min. Odorant concentrations, stimulus and inter-stimulus intervals, and flow rates were determined in a separate experiment and were chosen so that the odors were perceived as iso-intense and adaptation to the odors was minimal. Odorless air stimuli served as the placebo in the inhalation condition. During the 20 min inhalation period, subjects in all groups monitored the presentation of odor and air stimuli which was indicated by a "flashing red LED" on a computer screen. In the S condition, subjects in the CS group applied 1.0 mL of a 8.64% (v/v) dilution of C in peanut oil (pharmaceutical grade, DAB 10) to an area of approximately 20 x 10 cm 2 of the lower abdomen. Subjects in the LS group applied 1.0 mL of a 0.798% (v/v) dilution of L in peanut oil. The preparation was then massaged into the skin for 1-2 min. In order to prevent any olfactory stimulation in the skin application condition, subjects breathed odorless air via breathing masks.
Visual vigilance test:
A standard visual vigilance test [14] was used to assess cognitive performance. On a computer screen, subjects monitored a pattern that oscillated between 2 squares and had to press a response button as quickly as possible when the pattern appeared twice in the same square. The stimulus appeared at random intervals between 8,000 and 40,000 msec. Speed, i.e., RT and DR, and accuracy in terms of H, i.e., correct detection of the target stimulus, FA, i.e., reaction without appearance of the target stimulus, and M, i.e., no reaction to the target stimulus, were recorded. In each of the two trials, the vigilance task was performed for 30 min.
Physiological recordings:
Five physiological parameters were recorded simultaneously and in real time during the fragrance administration period with a portable, digital recording system (Physio-Logger, Rimkus Medizintechnik, 85599 Parsdorf, Germany). Electrode positioning was in accordance with standard positioning recommendations [15] [16] [17] . The ECG was recorded at 100 Hz with disposable Ag/AgCl electrode pads, which were placed on each side of the chest and IBI was obtained from the ECG. EMG was recorded with 2 Ag/AgCl electrodes filled with conductive gel and placed over the neck muscles (M. splenius, M. sternocleidomastoideus) on the nondominant side of the body. Neck muscle activity was expressed as the amplitude of the full-wave rectified raw EMG signal sampled at 10 Hz. BR was derived from the vertical electrooculogram (EOG), which was recorded at 20 Hz with 2 Ag/AgCl electrodes filled with conductive gel and placed over the orbicularis oculi muscle. Electrodermal activity was recorded via a constant voltage (0.5 V) technique with 2 Ag/AgCl electrodes placed over the thenar and hypothenar eminences, respectively, of the non-dominant hand. SCL was recorded at 2 Hz and NS-SCR were registered at 10 Hz. RR was derived from breathing movements which were recorded at 5 Hz with a piezoelectric respiration strap placed around the chest between the xiphoid process of the breast bone and the navel.
Subjective ratings: All subjects gave ratings of their well-being on 100 mm bipolar visual analog scales adopted from the 'Bf-S, Befindlichkeitsskala' [18] . Well-being was S (tense -relaxed), V (vigorous -feeble), C (calm -restless), AT (attentive -inattentive), M (cheerful -grumpy) and AL (alert -tired). In addition, subjects in the inhalation condition gave ratings of the perceived odors in terms of P (pleasant -unpleasant), I (weak -strong) and E (stimulating -tiring). Subjective ratings were obtained 4 times in each session, i.e., at the beginning and at the end of each of the 2 trials.
Procedure:
At the beginning of each individual session the procedures and the aim of the study were explained to the subject. Subjects were told that the effects of fragrances on well-being and vigilance performance were tested but they were kept naive about which fragrances were investigated and whether or not a fragrance would be administered to them. Also, in the I condition subjects were informed that the fragrances could be administered at subthreshold concentrations and could thus not be detectable. After handedness had been determined the electrodes were positioned as described above. In the inhalation condition, subjects were seated comfortably and the nose piece of the olfactometer was inserted into their right nostril. After the presentation of a single 'odor', i.e., air, stimulus subjects rated their well-being and the pleasantness, intensity and effect of the perceived odor. Then, subjects inhaled the stimuli presented by the olfactometer for the next 20 min while watching the flashing red light on the computer screen in front of them. After the first inhalation period subjects gave a second rating of their well-being and the perceived odor and had to perform the vigilance task for the next 30 min. The procedure was repeated in the second trial. However, during this trial the placebo, i.e., odorless air, was again administered to subjects in the PI group whereas C was administered to the CI group and L to the LI group.
In the S condition, after handedness had been determined and the electrodes had been positioned the breathing mask was affixed comfortably to the Effects of monoterpenes on arousal in humans Natural Product Communications Vol. 3 (7) 2008 1109 subject's nose and mouth. The air flow was adjusted individually so that the subject was able to breathe without any effort and air was streaming out from the exhaust tube of the mask even when the subject inhaled deeply. The latter procedure ensured that subjects were unable to perceive any odor present in the experimental room. Then, 1.0 mL of peanut oil was administered to the subject's dominant hand and the person was instructed to massage it into the skin of the lower abdomen until most of the oil had been absorbed. The so treated area was covered with plastic film and excess oil was removed from the hand of the subject. After the respiration strap had been fixed to the subject's chest he or she was comfortably seated and rated his or her well-being. Then, the subject sat quietly for 20 min. After the application period, the plastic foil and residual oil were removed from the subject's abdomen, the subject gave the second rating of well-being and engaged in the vigilance task for the following 30 min. This procedure was repeated in the second trial. However, subjects in the PS group received the placebo, i.e., peanut oil, whereas those in the CS and LS groups received the dilution of C and L in peanut oil, respectively. In the skin application condition, subjects did not remove the breathing mask at any point during the session. All subjects were fully debriefed at the end of the test session.
Data reduction:
Median RT, and the number of H, FA, M and DR in each trial of the vigilance task were computed for each subject. Individual differences that reflected the change from baseline to the second trial were calculated for each parameter by subtracting the value in the first trial from the value in the second trial. Mean values for each of the physiological parameters were obtained for each subject in each trial. Again, individual trial -baseline differences were calculated for every physiological parameter. The subjective ratings of well-being and the odor ratings were measured from the left hand end of each scale, and differences were calculated between the first and the third rating (Dif 3-1), and the second and the fourth rating (Dif 4-2).
Statistical analysis:
All statistical analyses were performed with Systat® 12 V.12.01.04 (SYSTAT Software Inc., San Jose, CA 95110, USA, © 2007). The correlation matrix of the differences obtained from the vigilance parameters was submitted to a principal component factor analysis (PCA) with orthogonal (varimax) rotation. The extracted principal components were then subjected to separate analyses of variance (ANOVA) with group (CI, LI, PI, CS, LS, PS) as the between-subjects factor. Planned post hoc comparisons were made with Fisher's least significant difference (LSD) tests. In addition, univariate ANOVAs with group (CI, LI, PI, CS, LS, PS) as the between-subjects factor were calculated on the differences and were followed by planned post hoc comparisons using Fisher's LSD tests.
The set of differences of the physiological parameters as well as the 2 sets of differences between the ratings of well-being (Dif 3-1 and Dif 4-2) were analyzed by the same procedures.
The differences between the first and third odor rating and the second and the fourth odor rating were subjected to ANOVAs with substance (C, L, P) as the between-subjects factor and were followed by planned comparisons with post hoc Fisher's LSD tests. In all tests, P values ≤ 0.05 were considered statistically significant.
